FDA LAUNCHES AI TOOL TO ACCELERATE DRUG REVIEWS AND INSPECTIONS

Summary from the TLDR AI newsletter

“Elsa” is available to all FDA employees, enabling faster clinical protocol reviews, shortened scientific evaluations, and improved identification of high-priority inspection targets. In one case, a review that would have taken 2-3 days was completed in just 6 minutes.